Human-skin substitute gets ad campaign

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

Ads for a human-skin substitute may sound like something out of Total Recall, but a Canton, Mass.-based company called Organogenesis has indeed launched a direct-to-consumer push for its living-cell-based Apligraf product. The work is decidedly restrained, contrasting wound care circa 1974 (antibacterial ointments and bandages) with an Apligraf patch, touted as “advanced therapy for wound care today.” The product is intended for the treatment of foot sores and leg ulcers, so it won’t help turn you into an entirely new person—yet.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in